Etid klinik pou VIH nan Texas
23 etid pou VIH ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, Dallas
- ak 2 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07650916ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
- Baylor College of Medicine, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06274632A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire
- Prism Health North Texas, Oak Cliff Health Center ( Site 1514), Dallas
- Texas Center for Infectious Disease Associates ( Site 1502), Fort Worth
- ak 1 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07266831Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Abounding Prosperity Inc., Dallas
- Prism Health, Dallas
- UT Health, Houston
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07473778Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Ap rekriteFaz 1/2
48 Hours · Tout sèks · Mizajou Sep 9, 2026 · NCT02140255Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
- M D Anderson Cancer Center, Houston
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 4, 2026 · NCT02479698A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
- The Crofoot Research Center, Houston
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Aug 21, 2026 · NCT07698600Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- University of Texas M.D. Anderson Cancer Center, Houston
Ap rekrite
Laj 45 a 80 · Tout sèks · Mizajou Aug 19, 2026 · NCT04949464Positive Peers Intervention Clinical Trial
- Thomas Street Clinic, Houston
Ap rekrite
Laj 13 a 34 · Tout sèks · Mizajou Aug 18, 2026 · NCT06388109Screen2Prevent (S2P)
- Baylor College of Medicine, Houston
Ap rekriteVolontè an sante akeyi
Laj 14 a 24 · Tout sèks · Mizajou Aug 17, 2026 · NCT07728123Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- North Texas Infectious Diseases Consultants, P.A., Dallas
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT07682961First Time in Human Study of Long Acting VH4524184 Formulations
- GSK Investigational Site, San Antonio
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Aug 10, 2026 · NCT06310551A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- UT Health Houston, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07143968A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Bellaire
- GSK Investigational Site, Dallas
- GSK Investigational Site, Houston
- ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07202546Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
- Houston Methodist Research Institute, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT06263426Menopausal HT for Women Living With HIV (HoT)
- Houston AIDS Research Team CRS (31473), Houston
Ap rekriteFaz 4
Laj 40 a 60 · Fanm · Mizajou May 22, 2026 · NCT06856174Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
- The University of Texas Health Science Center at Houston, Houston
Ap rekrite
Laj 18 a 25 · Tout sèks · Mizajou May 13, 2026 · NCT06074354HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- UT Southwestern Medical Center, Dallas
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 21, 2026 · NCT06659952The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
- UT Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Jan 15, 2026 · NCT07292792A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- GSK Investigational Site, Austin
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Dec 18, 2025 · NCT05418868Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- UT Health Houston, Houston
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT05488431A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
- GSK Investigational Site, Austin
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Oct 29, 2025 · NCT06724640Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Ap rekriteFaz 1/2
Laj 6 a 12 · Tout sèks · Mizajou Sep 19, 2024 · NCT05674656Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.